[HTML][HTML] Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population

R Calderon-Flores, G Caceres-Cardenas… - PLOS Global Public …, 2023 - journals.plos.org
Serological assays have been used in seroprevalence studies to inform the dynamics of
COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for …

Diagnostic performance of lateral flow immunoassays for COVID-19 antibodies in Peruvian population

R Calderon-Flores, G Caceres-Cardenas, K Alí… - medRxiv, 2023 - medrxiv.org
Background Serological assays have been used in seroprevalence studies to inform the
dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical …

Clinical utility of a highly sensitive lateral flow immunoassay as determined by titer analysis for the detection of anti-SARS-CoV-2 antibodies at the point-of-care

A Haymond, C Mueller, H Steinberg, KA Hodge… - medRxiv, 2020 - medrxiv.org
Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), became a pandemic in early 2020. Lateral flow …

Clinical characterisation of eleven lateral flow assays for detection of COVID-19 antibodies in a population

F Rudolf, HM Kaltenbach, J Linnik, MT Ruf… - MedRxiv, 2020 - medrxiv.org
Importance Serological assays can help diagnose and determine the rate of SARS-CoV-2
infections in a population. Objective We characterized and compared 11 different lateral flow …

Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey

B Flower, JC Brown, B Simmons, M Moshe, R Frise… - Thorax, 2020 - thorax.bmj.com
Background Accurate antibody tests are essential to monitor the SARS-CoV-2 pandemic.
Lateral flow immunoassays (LFIAs) can deliver testing at scale. However, reported …

[HTML][HTML] Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

SI Owen, CT Williams, G Garrod, AJ Fraser, S Menzies… - Journal of Infection, 2022 - Elsevier
Background There are an abundance of commercially available lateral flow assays (LFAs)
that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the …

Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection

MM Serrano, DN Rodriguez, NT Palop… - Journal of clinical …, 2020 - Elsevier
Background COVID-19 pandemic has spread worldwide since December 2019. Serological
tests for SARS-CoV-2 antibody testing are needed for detection of current or past infections …

Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2

JL Wu, WP Tseng, CH Lin, TF Lee, MY Chung… - Journal of Infection, 2020 - Elsevier
Objectives: We aimed to evaluate the role of rapid serological tests in the management of
coronavirus disease 2019 (COVID-19) patients. Methods: This retrospective study enrolled …

[HTML][HTML] Higher sensitivity provided by the combination of two lateral flow immunoassay tests for the detection of COVID-19 immunoglobulins

Z Daoud, J McLeod, DL Stockman - Frontiers in cellular and infection …, 2020 - frontiersin.org
SARS-Cov-2 was identified in Wuhan, China in December 2019. The World Health
Organization (WHO) declared it a pandemic in March of 2020. COVID-19 has now been …

[HTML][HTML] Comparative evaluation of ten lateral flow immunoassays to detect SARS-CoV-2 antibodies

G Garrod, SI Owen, JK Baillie… - Wellcome Open …, 2021 - wellcomeopenresearch.org
Background: Rapid mobilisation from industry and academia following the outbreak of the
novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to …